ArticleThe Journal of clinical investigation2020

TPL2 enforces RAS-induced inflammatory signaling and is activated by point mutations.

Paarth B Dodhiawala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.